Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: 5HT-2c and other receptors and targets in OCD

Posted by psychobot5000 on January 23, 2009, at 15:50:30

In reply to Re: Agomelatine effects on OCD... » desolationrower, posted by SLS on January 23, 2009, at 2:45:48

Did a google search and found this on an odd site which doesn't give its research sources. I haven't the time to find a better source, but I've read very similar things elsewhere recently. This one is better, though because it has a list of the neurological targets involved in OCD, segregated by their positive or negative correlation with OCD symptoms. Though I'm assuming much of their conclusions are unconfirmed, it makes me wonder what might be done with all this information to throw together a makeshift treatment or two. If I come up with anything, I'll mention it.

http://www.k12academics.com/ocd_neuropsychiatry.htm
________________________________________________
"OCD primarily involves the brain regions of the striatum and the cingulate cortex, especially the striatum. OCD involves several different receptors, mostly H2, M4, nk1, NMDA, and non-NMDA glutamate receptors. The receptors 5-HT1D, 5-HT2C, and the mu opioid receptor exert a secondary effect. The H2, M4, nk1, and non-NMDA glutamate receptors are active in the striatum, whereas the NMDA receptors are active in the cingulate cortex.

The activity of certain receptors is positively correlated to the severity of OCD, whereas the activity of certain other receptors is negatively correlated to the severity of OCD. Those correlations are as follows:

Activity positively correlated to severity:
H2
M4
nk1
non-NMDA glutamate receptors

Activity negatively correlated to severity:
NMDA
mu opioid
5-HT1D
5-HT2C

The central dysfunction of OCD involves the receptors nk1, non-NMDA glutamate receptors, and NMDA, whereas the other receptors exert secondary modulatory effects.

Pharmaceuticals that act directly on those core mechanisms are aprepitant (nk1 antagonist), riluzole (glutamate release inhibitor), and tautomycin (NMDA receptor sensitizer). The drugs that are popularly used to fight OCD lack efficacy because they do not act upon the core mechanisms."
__________________________________________(endquote)


Share
Tweet  

Thread

 

Post a new follow-up

Your message only Include above post


Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:psychobot5000 thread:869924
URL: http://www.dr-bob.org/babble/20090104/msgs/875649.html